CELZ stock icon

Creative Medical Technology


About: Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.

Employees: 4

Funds holding %
of 6,689 funds
Analysts bullish %
News positive %

Fund manager confidence

Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)

510% more capital invested

Capital invested by funds: $90.4K [Q4 2023] → $552K (+$461K) [Q1 2024]

250% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 2

63% more funds holding

Funds holding: 8 [Q4 2023] → 13 (+5) [Q1 2024]

6.38% more ownership

Funds ownership: 1.42% [Q4 2023] → 7.8% (+6.38%) [Q1 2024]

Research analyst outlook

We haven’t received any recent analyst ratings for CELZ.

Financial journalist opinion